Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
21.90
-0.03 (-0.14%)
Dec 5, 2025, 4:00 PM EST - Market closed
Evommune Market Cap
Evommune has a market cap or net worth of $658.70 million as of December 5, 2025.
Market Cap
658.70M
Enterprise Value
572.67M
1-Year Change
n/a
Ranking
Category
Stock Price
21.90
Market Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has increased from $481.24M to $658.70M, an increase of 36.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 658.70M | 36.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |